Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazoprevir/Elbasvir for Acute Hepatitis C Genotypes 1 or 4
NCT02886624Phase 2Completed
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of grazoprevir, elbasvir in hepatitis C virus infection. Started May 2017; status: completed.
02
Drugs
grazoprevirelbasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02886624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02886624.